Search research articles
Contact Us
Filters
Showing results (51-60 of 339) with videos related to
Page
of 34
Sort By:
European Journal of Cancer & Clinical Oncology
|
April 1, 1982
In vitro cytotoxicity of VP 16 on primary tumor and metastasis of Lewis lung carcinoma
M D'Incalci, E Erba, M Vaghi, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
May 1, 1982
Routes of elimination of hexamethylmelamine and pentamethylmelamine in the rat
T Colombo, M Broggini, A Gescher, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Potentiation of etoposide cytotoxicity against a human ovarian cancer cell line by pretreatment with non-toxic concentrations of methotrexate or aphidicolin
E Erba, S Sen, A Lorico, et al.
Cancer Treatment Reports
|
August 1, 1979
Hexamethylmelamine in ovarian cancer resistant to cyclophosphamide and adriamycin
G Bolis, M D'Incalci, C Belloni, et al.
Analytical Biochemistry
|
April 1, 1993
Flow-cytometric measurement of histone H1o in human cells
L Srebreva, P Ubezio, F Civoli, et al.
Carcinogenesis
|
September 1, 1993
Differential inhibition of the DNA binding of transcription factors NF kappa B and OTF-1 by nitrogen mustard and quinacrine mustard: transcriptional implications
S Fabbri, C Prontera, M Broggini, et al.
Life Sciences
|
January 14, 1980
N-Hydroxymethylpentamethylmelamine, a major in vitro metabolite of hexamethylmelamine
A Gescher, M D'Incalci, R Fanelli, et al.
Cancer Treatment Reports
|
January 1, 1982
Hexamethylmelamine and pentamethylmelamine tissue distribution in M5076/73A ovarian cancer-bearing mice
M Broggini, C Rossi, T Colombo, et al.
Nucleic Acids Research
|
October 25, 1991
O6-methylguanine inhibits the binding of transcription factors to DNA
M Bonfanti, M Broggini, C Prontera, et al.
Cancer Treatment Reports
|
March 1, 1981
Cerebrospinal fluid levels of hexamethylmelamine and N-demethylated metabolites
M D'Incalci, C Sessa, G Beggiolin, et al.
Page
of 34
Search research articles
Search
Showing results (51-60 of 339) with videos related to
Sort By:
Page
of 34
European Journal of Cancer & Clinical Oncology
|
April 1, 1982
In vitro cytotoxicity of VP 16 on primary tumor and metastasis of Lewis lung carcinoma
M D'Incalci, E Erba, M Vaghi, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
May 1, 1982
Routes of elimination of hexamethylmelamine and pentamethylmelamine in the rat
T Colombo, M Broggini, A Gescher, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Potentiation of etoposide cytotoxicity against a human ovarian cancer cell line by pretreatment with non-toxic concentrations of methotrexate or aphidicolin
E Erba, S Sen, A Lorico, et al.
Cancer Treatment Reports
|
August 1, 1979
Hexamethylmelamine in ovarian cancer resistant to cyclophosphamide and adriamycin
G Bolis, M D'Incalci, C Belloni, et al.
Analytical Biochemistry
|
April 1, 1993
Flow-cytometric measurement of histone H1o in human cells
L Srebreva, P Ubezio, F Civoli, et al.
Carcinogenesis
|
September 1, 1993
Differential inhibition of the DNA binding of transcription factors NF kappa B and OTF-1 by nitrogen mustard and quinacrine mustard: transcriptional implications
S Fabbri, C Prontera, M Broggini, et al.
Life Sciences
|
January 14, 1980
N-Hydroxymethylpentamethylmelamine, a major in vitro metabolite of hexamethylmelamine
A Gescher, M D'Incalci, R Fanelli, et al.
Cancer Treatment Reports
|
January 1, 1982
Hexamethylmelamine and pentamethylmelamine tissue distribution in M5076/73A ovarian cancer-bearing mice
M Broggini, C Rossi, T Colombo, et al.
Nucleic Acids Research
|
October 25, 1991
O6-methylguanine inhibits the binding of transcription factors to DNA
M Bonfanti, M Broggini, C Prontera, et al.
Cancer Treatment Reports
|
March 1, 1981
Cerebrospinal fluid levels of hexamethylmelamine and N-demethylated metabolites
M D'Incalci, C Sessa, G Beggiolin, et al.
Page
of 34